Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/II Study of Micro-needle Array Containing Doxorubicin in Immune Competent or Immune-suppressed Patients With Cutaneous Squamous Cell Carcinoma

NCT05377905 is registered in ClinicalTrials.gov with Falo, Louis, MD as lead sponsor.

NCT NCT05377905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05377905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/II Study of Micro-needle Array Containing Doxorubicin in Immune Competent or Immune-suppressed Patients With Cutaneous Squamous Cell Carcinoma
Lead sponsor
Falo, Louis, MD
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 13, 2023
Completion date
December 31, 2027
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous squamous cell carcinoma, skin cancers - squamous cell carcinoma